Despite the growing number of evidence, the association between circulating Cathepsin B levels and Parkinson’s Disease risk is still uncertain, primarily due to the small sample sizes of the studies, limited follow-up duration, and the potential risk of reverse causality. Here, CTSB is linked to Parkinson disease.